Financials
- Market Capitalization 508.15 M
- Employee 2 842
- Founded 2013
- CEO Irwin D.Simon
- Website www.tilray.com
- Headquarter New York, United States
- FIGI BBG00L7XTP60
- Industry Case Farmaceutiche - Specialistico e Generico
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.17
Rapporto prezzo/fatturato
0.44
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2602 | ESPR Esperion Therapeutics, Inc. - Common Stock | 3.18 USD | 0.00% | +0.63% | +0.63% | +169.49% | 818.63 M USD | ||
| 2703 | IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock | 4.02 USD | -4.51% | -9.46% | +6.63% | +443.24% | 661.75 M USD | ||
| 2911 | AQST Aquestive Therapeutics, Inc. - Common Stock | 4.03 USD | -0.74% | -5.40% | -4.28% | -0.25% | 505.56 M USD | ||
| 3034 | EOLS Evolus, Inc. - Common Stock | 6.50 USD | -0.31% | -7.01% | -3.85% | -32.29% | 428.06 M USD |